Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.

Pharmaceutical

Aytu BioScience

Josh Disbrow

Victoria Cordova

Ryan Selhorn

Mark Oki

Russ McMahen

Greg Pyszczymuka

Margaret Cabano

Suzane Kennedy

Jarrett Disbrow

The board of directors at Aytu BioScience has a history of experience in the healthcare industry, with members having worked as a financial advisor, business development executive, and CEO at various companies. They also have a background in religion, holding degrees from seminary and university programs in philosophy and religion.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Aytu BioScience

Leadership Team

CEO and Executive Team